Patents by Inventor Akifumi TAKAORI

Akifumi TAKAORI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for use in prevention or treatment of cancer
    Patent number: 9457028
    Abstract: Abacavir, a nucleoside analog reverse transcriptase inhibitor, has been found to exhibit an anti-cancer activity on ATL cells in vitro without inhibiting DNA replication of normal cells. Abacavir or a pharmaceutically acceptable derivative thereof is useful as an active ingredient of a pharmaceutical composition for use in the prevention or the treatment of cancer, in particular a cancer whose DNA repair system is impaired such as breast cancer or adult T-cell leukemia.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: October 4, 2016
    Assignee: KYOTO UNIVERSITY
    Inventors: Akifumi Takaori, Shunichi Takeda, Masayuki Kobayashi, Kohei Tada
  • LSD1-selective inhibitor having lysine structure
    Patent number: 9388123
    Abstract: Provided is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: [in the formula, R1 to R5, A, and *1 to *3 are as defined in Description].
    Type: Grant
    Filed: November 28, 2013
    Date of Patent: July 12, 2016
    Assignee: Kyoto University
    Inventors: Takayoshi Suzuki, Yukihiro Itoh, Daisuke Ogasawara, Naoki Miyata, Tamio Mizukami, Ryuzo Sasaki, Akifumi Takaori, Masahiro Kawahara
  • LSD1-SELECTIVE INHIBITOR HAVING LYSINE STRUCTURE
    Publication number: 20160039748
    Abstract: Provided is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: [in the formula, R1 to R5, A, and *1 to *3 are as defined in Description].
    Type: Application
    Filed: November 28, 2013
    Publication date: February 11, 2016
    Inventors: Takayoshi SUZUKI, Yukihiro ITOH, Daisuke OGASAWARA, Naoki MIYATA, Tamio MIZUKAMI, Ryuzo SASAKI, Akifumi TAKAORI, Masahiro KAWAHARA
  • PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION OR TREATMENT OF CANCER
    Publication number: 20160000796
    Abstract: Abacavir, a nucleoside analogue reverse transcriptase inhibitor, has been found to exhibit an anti-cancer activity on ATL cells in vitro without inhibiting DNA replication of normal cells. Abacavir or a pharmaceutically acceptable derivative thereof is useful as an active ingredient of a pharmaceutical composition for use in the prevention or the treatment of cancer, in particular a cancer whose DNA repair system is impaired such as breast cancer or adult T-cell leukemia.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 7, 2016
    Inventors: Akifumi TAKAORI, Shunichi TAKEDA, Masayuki KOBAYASHI, Kohei TADA